rifapentine (M000473) + EFZ EMT TDF
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tuberculosis
Conditions
Tuberculosis
Trial Timeline
Dec 1, 2012 → Mar 1, 2014
NCT ID
NCT01690403About rifapentine (M000473) + EFZ EMT TDF
rifapentine (M000473) + EFZ EMT TDF is a phase 1 stage product being developed by Sanofi for Tuberculosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01690403. Target conditions include Tuberculosis.
What happened to similar drugs?
3 of 5 similar drugs in Tuberculosis were approved
Approved (3) Terminated (1) Active (2)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01690403 | Phase 1 | Completed |
Competing Products
20 competing products in Tuberculosis